AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Feb 4, 2015
30583_dirs_2015-02-04_8d75edc7-39a0-4398-bda1-0d7e5c8f2fa2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-12-31
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-31 | Common Stock | G | 1000 | — | Disposed | 226157 | Direct |
| 2014-10-29 | Common Stock | G | 7011 | — | Disposed | 36184 | Indirect |
| 2014-10-29 | Common Stock | G | 7011 | — | Acquired | 233168 | Direct |
| 2014-11-13 | Common Stock | G | 2400 | — | Disposed | 230768 | Direct |
Footnotes
F1: On October 29, 2014 the reporting person transferred 7,011 shares of common stock from his family trust to his personal account. The reporting person and his spouse are trustees.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19